Boston Scientific is trading 4.01% up now at $48.72, after a gain with no clearly identified fresh company-specific catalyst.
- Available August 31, 2026 coverage identifies the latest disclosed development as an August 29 cybersecurity incident update.
- Reuters reported the operational disruption began August 25.
- Broader markets are lower, so the move does not clearly track overall market direction.